Answer
No, the safety and efficacy of Efavirenz/Emtricitabine/Tenofovir disoproxil Glenmark have not been established in children under 18 years.
Sources for this answer
- Efavirenz/Emtricitabine/Tenofovir disoproxil Glenmark 600 mg/ 200 mg/245 mg film-coated tabletsGlenmark Pharmaceuticals Europe Ltd · emc · SmPC §4.2 Posology and method of administration · Version 5Document updated
Sources checked